Related Experiment Video
Updated: Oct 16, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball
Ana Herrero1,2, Piero Crespo1,2
1Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Cantabria, 39011 Santander, Spain.
Abstract:
Signals conveyed through the RAS-ERK pathway constitute a pivotal regulatory element in cancer-related cellular processes. Recently, RAS dimerization has been proposed as a key step in the relay of RAS signals, critically contributing to RAF activation. RAS clustering at plasma membrane microdomains and endomembranes facilitates RAS dimerization in response to stimulation, promoting RAF dimerization and subsequent activation. Remarkably, inhibiting RAS dimerization forestalls tumorigenesis in cellular and animal models. Thus, the pharmacological disruption of RAS dimers has emerged as an additional target for cancer researchers in the quest for a means to curtail aberrant RAS activity.
Insights
RAS protein dimerization is crucial for cancer cell signaling and RAF activation. Inhibiting RAS dimers halts tumor growth, offering a new cancer treatment strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The RAS-ERK pathway is a key regulator of cancer-related cellular processes.
- RAS protein dimerization is increasingly recognized as a critical step in RAS signal transduction.
- RAS clustering at cellular membranes promotes dimerization and subsequent RAF activation.
Purpose of the Study:
- To investigate the role of RAS dimerization in cancer.
- To explore the potential of targeting RAS dimers for cancer therapy.
Main Methods:
- The study focuses on the mechanism of RAS dimerization and its impact on RAF activation.
- Inhibition of RAS dimerization was tested in cellular and animal cancer models.
Main Results:
- RAS dimerization facilitates RAF activation by promoting clustering at membrane microdomains.
- Inhibiting RAS dimerization effectively prevented tumorigenesis in preclinical models.
Conclusions:
- RAS dimerization is a critical event in oncogenic RAS signaling.
- Targeting RAS dimers represents a promising therapeutic strategy for cancers driven by aberrant RAS activity.
Related Concept Videos
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Tyrosine Kinases
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...

